0000899243-22-001475.txt : 20220110
0000899243-22-001475.hdr.sgml : 20220110
20220110163041
ACCESSION NUMBER: 0000899243-22-001475
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220103
FILED AS OF DATE: 20220110
DATE AS OF CHANGE: 20220110
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Rajavelu Esther
CENTRAL INDEX KEY: 0001903716
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38978
FILM NUMBER: 22521611
MAIL ADDRESS:
STREET 1: 26 LANDSDOWNE STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Fulcrum Therapeutics, Inc.
CENTRAL INDEX KEY: 0001680581
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 474839948
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 26 LANDSDOWNE STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-651-8851
MAIL ADDRESS:
STREET 1: 26 LANDSDOWNE STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-01-03
0
0001680581
Fulcrum Therapeutics, Inc.
FULC
0001903716
Rajavelu Esther
C/O FULCRUM THERAPEUTICS, INC.
26 LANDSDOWNE STREET
CAMBRIDGE
MA
0
1
0
0
Chief Financial Officer
Stock Option (right to buy)
17.82
2022-01-03
4
A
0
200000
0.00
A
2032-01-02
Common Stock
200000
200000
D
This option was granted on January 3, 2022 and is scheduled to vest 25% on the first anniversary of the vesting commencement date of January 3, 2022. The remainder of the shares underlying the grant shall vest in equal quarterly installments over the following three years until the fourth anniversary of the vesting commencement date, subject to continued service.
/s/ Peter Thomson, as attorney-in-fact for Esther Rajavelu
2022-01-10